Outlook Therapeutics Inc. (OTLK)
undefined
undefined%
At close: undefined
2.40
0.63%
Pre-market Jan 07, 2025, 04:33 AM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14
PE Ratio -0.00 -0.94 -3.92 -6.23 -1.48 -0.79 -3.09 -0.85 -1.37 -1.35 -4.4
PS Ratio n/a n/a n/a n/a n/a 3.33 46.19 8.63 24.55 12.30 6.67
PB Ratio -0.00 -3.83 29.62 71.91 18.49 -2.52 -6.85 -1.07 -14.07 -2.73 -2.11
P/FCF Ratio -0.00 -1.29 -4.57 -6.11 -1.64 -0.83 -3.98 -2.08 -1.57 -1.77 -6.43
P/OCF Ratio -0.00 -1.29 -4.57 -6.11 -1.64 -0.84 -4.32 -2.12 -1.61 -2.34 -8.6
OCF/S Ratio n/a n/a n/a n/a n/a -3.96 -10.7 -4.07 -15.26 -5.26 -0.78
Debt / Equity Ratio -0.00 -2.46 1.25 2.56 1.62 -1.06 -0.86 -0.59 -1.43 -0.84 -0.7
Quick Ratio 0.64 0.66 1.39 3.19 1.13 0.67 0.10 0.14 0.28 0.16 0.41
Current Ratio 0.64 0.66 1.39 3.19 1.13 0.67 0.10 0.14 0.28 0.16 0.41
Asset Turnover n/a n/a n/a n/a n/a 0.48 0.14 0.18 0.13 0.45 0.26
Interest Coverage -22.71 -34.06 -42.4 -55.26 -20.98 -10.47 -6.54 -6.38 -35.26 -20.27 -13.75
Return on Equity (ROE) 1.03 4.09 -7.56 -11.54 -12.47 3.21 2.22 1.26 10.26 2.01 0.48
Return on Assets (ROA) -2.61 -1.83 -2.32 -2.33 -1.79 -2.01 -2.07 -1.87 -2.25 -4.08 -0.39
Return on Capital (ROIC) 5.22 3.68 -7.17 -3.22 -9.58 11.50 2.61 4.48 -15.83 5.41 6.10
Dividend Yield n/a n/a n/a n/a n/a n/a 13.23K 516.10 n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a -40.92K -437.2 n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a 99.71% 99.40% 99.38% 98.90% 99.26% 99.84%
Net Profit Margin n/a n/a n/a n/a n/a -423.81% -1.49K% -1.02K% -1.79K% -908.05% -151.73%
Pretax Profit Margin n/a n/a n/a n/a n/a -465.68% -1.09K% -1.01K% -1.79K% -936.15% -146.88%
Operating Profit Margin n/a n/a n/a n/a n/a -445.6% -824.09% -941.36% -1.74K% -892.13% -136.92%
FCF Margin n/a n/a n/a n/a n/a -401.75% -1.16K% -414.46% -1.56K% -695.13% -103.72%
EBITDA Margin n/a n/a n/a n/a n/a -381.85% -867.82% -787.87% -1.64K% -857.18% -127.22%